12726 related articles for article (PubMed ID: 10518979)
21. Regional Radiation Therapy Impacts Outcome for Node-Positive Cutaneous Melanoma.
Strom T; Torres-Roca JF; Parekh A; Naghavi AO; Caudell JJ; Oliver DE; Messina JL; Khushalani NI; Zager JS; Sarnaik A; Mulé JJ; Trotti AM; Eschrich SA; Sondak VK; Harrison LB
J Natl Compr Canc Netw; 2017 Apr; 15(4):473-482. PubMed ID: 28404758
[No Abstract] [Full Text] [Related]
22. Treatment of locally recurrent rectal carcinoma--results and prognostic factors.
Wong CS; Cummings BJ; Brierley JD; Catton CN; McLean M; Catton P; Hao Y
Int J Radiat Oncol Biol Phys; 1998 Jan; 40(2):427-35. PubMed ID: 9457832
[TBL] [Abstract][Full Text] [Related]
23. Tumor mitotic rate added to the equation: melanoma prognostic factors changed? : a single-institution database study on the prognostic value of tumor mitotic rate for sentinel lymph node status and survival of cutaneous melanoma patients.
Speijers MJ; Bastiaannet E; Sloot S; Suurmeijer AJ; Hoekstra HJ
Ann Surg Oncol; 2015 Sep; 22(9):2978-87. PubMed ID: 25605514
[TBL] [Abstract][Full Text] [Related]
24. The postoperative adjuvant radiation therapy and radiochemotherapy for UICC stage II and III rectal cancer. A retrospective analysis.
Bagatzounis A; Willner J; Oppitz U; Flentje M
Strahlenther Onkol; 2000 Mar; 176(3):112-7. PubMed ID: 10742831
[TBL] [Abstract][Full Text] [Related]
25. Primary mucosal melanoma of the head and neck. Comparison of clinical presentation and histopathologic features of oral and sinonasal melanoma.
McLean N; Tighiouart M; Muller S
Oral Oncol; 2008 Nov; 44(11):1039-46. PubMed ID: 18396446
[TBL] [Abstract][Full Text] [Related]
26. Hyperthermia as an adjuvant to radiation therapy of recurrent or metastatic malignant melanoma. A multicentre randomized trial by the European Society for Hyperthermic Oncology.
Overgaard J; Gonzalez Gonzalez D; Hulshof MC; Arcangeli G; Dahl O; Mella O; Bentzen SM
Int J Hyperthermia; 1996; 12(1):3-20. PubMed ID: 8676005
[TBL] [Abstract][Full Text] [Related]
27. Long-term follow-up of 163 consecutive patients treated with isolated limb perfusion for in-transit metastases of malignant melanoma.
Olofsson R; Mattsson J; Lindnér P
Int J Hyperthermia; 2013 Sep; 29(6):551-7. PubMed ID: 23865737
[TBL] [Abstract][Full Text] [Related]
28. Metastasectomy for distant metastatic melanoma: analysis of data from the first Multicenter Selective Lymphadenectomy Trial (MSLT-I).
Howard JH; Thompson JF; Mozzillo N; Nieweg OE; Hoekstra HJ; Roses DF; Sondak VK; Reintgen DS; Kashani-Sabet M; Karakousis CP; Coventry BJ; Kraybill WG; Smithers BM; Elashoff R; Stern SL; Cochran AJ; Faries MB; Morton DL
Ann Surg Oncol; 2012 Aug; 19(8):2547-55. PubMed ID: 22648554
[TBL] [Abstract][Full Text] [Related]
29. Results and prognostic factors in the retreatment of locally recurrent nasopharyngeal carcinoma.
Hwang JM; Fu KK; Phillips TL
Int J Radiat Oncol Biol Phys; 1998 Jul; 41(5):1099-111. PubMed ID: 9719121
[TBL] [Abstract][Full Text] [Related]
30. Locally advanced melanoma: results of postoperative hypofractionated radiation therapy.
Stevens G; Thompson JF; Firth I; O'Brien CJ; McCarthy WH; Quinn MJ
Cancer; 2000 Jan; 88(1):88-94. PubMed ID: 10618610
[TBL] [Abstract][Full Text] [Related]
31. Lymph node ratio has impact on relapse and outcome in patients with stage III melanoma.
Tas F; Erturk K
Int J Clin Oncol; 2019 Jun; 24(6):721-726. PubMed ID: 30788673
[TBL] [Abstract][Full Text] [Related]
32. Long-Term Oncologic Outcomes After Isolated Limb Infusion for Locoregionally Metastatic Melanoma: An International Multicenter Analysis.
Miura JT; Kroon HM; Beasley GM; Mullen D; Farrow NE; Mosca PJ; Lowe MC; Farley CR; Kim Y; Naqvi SMH; Potdar A; Daou H; Sun J; Farma JM; Henderson MA; Speakman D; Serpell J; Delman KA; Mark Smithers B; Coventry BJ; Tyler DS; Thompson JF; Zager JS
Ann Surg Oncol; 2019 Aug; 26(8):2486-2494. PubMed ID: 30911949
[TBL] [Abstract][Full Text] [Related]
33. Locoregional recurrence of breast cancer following mastectomy: always a fatal event? Results of univariate and multivariate analysis.
Willner J; Kiricuta IC; Kölbl O
Int J Radiat Oncol Biol Phys; 1997 Mar; 37(4):853-63. PubMed ID: 9128962
[TBL] [Abstract][Full Text] [Related]
34. Radiation therapy field extent for adjuvant treatment of axillary metastases from malignant melanoma.
Beadle BM; Guadagnolo BA; Ballo MT; Lee JE; Gershenwald JE; Cormier JN; Mansfield PF; Ross MI; Zagars GK
Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1376-82. PubMed ID: 18774657
[TBL] [Abstract][Full Text] [Related]
35. Enhancement of local control in locally advanced node-positive nasopharyngeal carcinoma by adjunctive chemotherapy.
Teo PM; Chan AT; Lee WY; Leung TW; Johnson PJ
Int J Radiat Oncol Biol Phys; 1999 Jan; 43(2):261-71. PubMed ID: 10030248
[TBL] [Abstract][Full Text] [Related]
36. [Long-term locally-recurrent melanoma].
Bach AG; Marsch WC; Richter C; Lübbe D; Helmbold P
Hautarzt; 2005 Oct; 56(10):949-54. PubMed ID: 15662535
[TBL] [Abstract][Full Text] [Related]
37. Isolated limb infusion for malignant melanoma: predictors of response and outcome.
Barbour AP; Thomas J; Suffolk J; Beller E; Smithers BM
Ann Surg Oncol; 2009 Dec; 16(12):3463-72. PubMed ID: 19830498
[TBL] [Abstract][Full Text] [Related]
38. Survival analysis and clinicopathological factors associated with false-negative sentinel lymph node biopsy findings in patients with cutaneous melanoma.
Nowecki ZI; Rutkowski P; Nasierowska-Guttmejer A; Ruka W
Ann Surg Oncol; 2006 Dec; 13(12):1655-63. PubMed ID: 17016755
[TBL] [Abstract][Full Text] [Related]
39. Malignant melanoma in Turkey: a single institution's experience on 475 cases.
Tas F; Kurul S; Camlica H; Topuz E
Jpn J Clin Oncol; 2006 Dec; 36(12):794-9. PubMed ID: 17060409
[TBL] [Abstract][Full Text] [Related]
40. Malignant melanoma: a retrospective series from a regional cancer center in India.
Sharma K; Mohanti BK; Rath GK
J Cancer Res Ther; 2009; 5(3):173-80. PubMed ID: 19841558
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
